Back to Results
First PageMeta Content
Medicine / Clinical medicine / Chemistry / Pyrimidines / Piperazines / Pyridines / Organofluorides / Orphan drugs / Chronic myelogenous leukemia / Philadelphia chromosome / Bcr-Abl tyrosine-kinase inhibitor / Imatinib


Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia Kevin Leder1., Jasmine Foo2., Brian Skaggs3, Mercedes Gorre4, Charles L. Sawyers5, Franziska
Add to Reading List

Document Date: 2011-12-13 09:42:07


Open Document

File Size: 694,46 KB

Share Result on Facebook